Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Published in: Reviews in Endocrine and Metabolic Disorders 2/2016

01-06-2016

Lipids and obesity: Also a matter of taste?

Author: Philippe Besnard

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 2/2016

Login to get access

Abstract

Obesity is undoubtedly one of the major public health challenges worldwide because of its rapid progression and deleterious effects of associated diseases. The easier access to tasty and energy-dense foods is thought to greatly contribute to this epidemic. Studies also report that obese subjects and animals (rats and mice) preferentially consume foods rich in fat when they can choose. The origin of this eating behavior remains elusive. Over the last decade, the existence of a taste of fat, besides textural and olfactory cues, was supported by a growing number of studies. The existence of a sixth taste modality devoted to the detection/perception of dietary lipids might offer additive information on the quality of food. While the sense of taste is recognized to be a driving-force guiding food choice, interest in the putative relationships between lipids, gustation and obesity is only now emerging. This mini-review will attempt to summarize our current knowledge on this new field of research.
Literature
1.
2.
Drewnowski A, Brunzell JD, Sande K, Iverius PH, Greenwood MR. Sweet tooth reconsidered: taste responsiveness in human obesity. Physiol Behav. 1985;35:617–22.PubMedCrossRef
3.
Mela DJ, Sacchetti DA. Sensory preferences for fats: relationships with diet and body composition. Am J Clin Nutr. 1991;53:908–15.PubMed
4.
White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG. Development and validation of the food-craving inventory. Obes Res. 2002;10:107–14.PubMedCrossRef
5.
Laugerette F, Passilly-Degrace P, Patris B, Niot I, Febbraio M, Montmayeur JP, Besnard P. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J Clin Invest. 2005;115:3177–84.PubMedPubMedCentralCrossRef
6.
Cartoni C, Yasumatsu K, Ohkuri T, Shigemura N, Yoshida R, Godinot N, le Coutre J, Ninomiya Y, Damak S. Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci. 2010;30:8376–82.PubMedCrossRef
7.
Simons PJ, Kummer JA, Luiken JJ, Boon L. Apical CD36 immunolocalization in human and porcine taste buds from circumvallate and foliate papillae. Acta Histochem. 2011;113:839–43.PubMedCrossRef
8.
Galindo MM, Voigt N, Stein J, van Lengerich J, Raguse JD, Hofmann T, Meyerhof W, Behrens M. G protein-coupled receptors in human fat taste perception. Chem Senses. 2012;37:123–39.PubMedCrossRef
9.
Pepino MY, Love-Gregory L, Klein S, Abumrad NA. The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects. J Lipid Res. 2012;53:561–6.PubMedPubMedCentralCrossRef
10.
Besnard P, Passilly-Degrace P, Khan NA. Taste of fat: a sixth taste modality? Physiol Rev. 2016;96:151–76.PubMedCrossRef
11.
Heinze JM, Preissl H, Fritsche A, Frank S. Controversies in fat perception. Physiol Behav. 2015;152:479–93.PubMedCrossRef
12.
Power ML, Schulkin J. Anticipatory physiological regulation in feeding biology: cephalic phase responses. Appetite. 2008;50:194–206.PubMedCrossRef
13.
Rolls ET. Taste, olfactory, and food reward value processing in the brain. Prog Neurobiol. 2015;127-128:64–90.PubMedCrossRef
14.
Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20:1–25.PubMedCrossRef
15.
16.
Li JX, Yoshida T, Monk KJ, Katz DB. Lateral hypothalamus contains two types of palatability-related taste responses with distinct dynamics. J Neurosci. 2013;33:9462–73.PubMedPubMedCentralCrossRef
17.
Davis JF, Choi DL, Benoit SC. Insulin, leptin and reward. Trends Endocrinol Metab. 2010;21:68–74.PubMedCrossRef
18.
19.
20.
Takeda M, Imaizumi M, Fushiki T. Preference for vegetable oils in the two-bottle choice test in mice. Life Sci. 2000;67:197–204.PubMedCrossRef
21.
Fukuwatari T, Shibata K, Iguchi K, Saeki T, Iwata A, Tani K, Sugimoto E, Fushiki T. Role of gustation in the recognition of oleate and triolein in anosmic rats. Physiol Behav. 2003;78:579–83.PubMedCrossRef
22.
Chale-Rush A, Burgess JR, Mattes RD. Evidence for human orosensory (taste?) sensitivity to free fatty acids. Chem Senses. 2007;32:423–31.PubMedCrossRef
23.
Kawai T, Fushiki T. Importance of lipolysis in oral cavity for orosensory detection of fat. Am J Phys Regul Integr Comp Phys. 2003;285:R447–54.
24.
Fukuwatari T, Kawada T, Tsuruta M, Hiraoka T, Iwanaga T, Sugimoto E, Fushiki T. Expression of the putative membrane fatty acid transporter (FAT) in taste buds of the circumvallate papillae in rats. FEBS Lett. 1997;414:461–4.PubMedCrossRef
25.
Chen CS, Bench EM, Allerton TD, Schreiber AL, Arceneaux 3rd KP, Primeaux SD. Preference for linoleic acid in obesity-prone and obesity-resistant rats is attenuated by the reduction of CD36 on the tongue. Am J Phys Regul Integr Comp Phys. 2013;305:R1346–55.
26.
Love-Gregory L, Abumrad NA. CD36 genetics and the metabolic complications of obesity. Curr Op Clin Nutr Metab Care. 2011;14:527–34.CrossRef
27.
Sclafani A, Zukerman S, Ackroff K. GPR40 and GPR120 fatty acid sensors are critical for postoral but not oral mediation of fat preferences in the mouse. Am J Phys Regul Integr Comp Phys. 2013;305:R1490–7.
28.
Ancel D, Bernard A, Subramaniam S, Hirasawa A, Tsujimoto G, Hashimoto T, Passilly-Degrace P, Khan NA, Besnard P. The oral lipid sensor GPR120 is not indispensable for the orosensory detection of dietary lipids in the mouse. J Lipid Res. 2016;56:369–78.CrossRef
29.
Godinot N, Yasumatsu K, Barcos ME, Pineau N, Ledda M, Viton F, Ninomiya Y, le Coutre J, Damak S. Activation of tongue-expressed GPR40 and GPR120 by non caloric agonists is not sufficient to drive preference in mice. Neurosci. 2013;250:20–30.CrossRef
30.
Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005;11:90–4.PubMedCrossRef
31.
Martin C, Passilly-Degrace P, Chevrot M, Ancel D, Sparks SM, Drucker DJ, Besnard P. Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity. J Lipid Res. 2012;53:2256–65.PubMedPubMedCentralCrossRef
32.
Martin B, Dotson CD, Shin YK, Ji S, Drucker DJ, Maudsley S, Munger SD. Modulation of taste sensitivity by GLP-1 signaling in taste buds. Ann N Y Acad Sci. 2009;1170:98–101.PubMedPubMedCentralCrossRef
33.
Gaillard D, Laugerette F, Darcel N, El-Yassimi A, Passilly-Degrace P, Hichami A, Khan NA, Montmayeur JP, Besnard P. The gustatory pathway is involved in CD36-mediated orosensory perception of long-chain fatty acids in the mouse. FASEB J. 2008;22:1458–68.PubMedCrossRef
34.
El-Yassimi A, Hichami A, Besnard P, Khan NA. Linoleic acid induces calcium signaling, Src kinase phosphorylation, and neurotransmitter release in mouse CD36-positive gustatory cells. J Biol Chem. 2008;283:12949–59.PubMedCrossRef
35.
Ozdener MH, Subramaniam S, Sundaresan S, Sery O, Hashimoto T, Asakawa Y, Besnard P, Abumrad NA, Khan NA. CD36- and GPR120-mediated Ca(2)(+) signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice. Gastroenterology. 2014;146:995–1005.PubMedPubMedCentralCrossRef
36.
Dramane G, Abdoul-Azize S, Hichami A, Vogtle T, Akpona S, Chouabe C, Sadou H, Nieswandt B, Besnard P, Khan NA. STIM1 regulates calcium signaling in taste bud cells and preference for fat in mice. J Clin Invest. 2012;122:2267–82.PubMedPubMedCentralCrossRef
37.
Sclafani A, Zukerman S, Glendinning JI, Margolskee RF. Fat and carbohydrate preferences in mice: the contribution of alpha-gustducin and Trpm5 taste-signaling proteins. Am J Phys Regul Integr Comp Phys. 2007;293:R1504–13.
38.
39.
De Araujo IE, Rolls ET. Representation in the human brain of food texture and oral fat. J Neurosci. 2004;24:3086–93.PubMedCrossRef
40.
Rolls ET. Mechanisms for sensing fat in food in the mouth: presented at the symposium “the taste for fat: new discoveries on the role of fat in sensory perception, metabolism, sensory pleasure and beyond” held at the Institute of Food Technologists 2011 annual meeting, New Orleans, LA, USA., June 12, 2011. J Food Sci. 2012;77:S140–2.PubMedCrossRef
41.
Verhagen JV, Rolls ET, Kadohisa M. Neurons in the primate orbitofrontal cortex respond to fat texture independently of viscosity. J Neurophysiol. 2003;90:1514–25.PubMedCrossRef
42.
Eldeghaidy S, Marciani L, McGlone F, Hollowood T, Hort J, Head K, Taylor AJ, Busch J, Spiller RC, Gowland PA, Francis ST. The cortical response to the oral perception of fat emulsions and the effect of taster status. J Neurophysiol. 2011;105:2572–81.PubMedPubMedCentralCrossRef
43.
Shin AC, Berthoud HR. Food reward functions as affected by obesity and bariatric surgery. Int J Obes. 2011;35(Suppl 3):S40–4.CrossRef
44.
Chevrot M, Passilly-Degrace P, Ancel D, Bernard A, Enderli G, Gomes M, Robin I, Issanchou S, Verges B, Nicklaus S, Besnard P. Obesity interferes with the orosensory detection of long-chain fatty acids in humans. Am J Clin Nutr. 2014;99:975–83.PubMedCrossRef
45.
Keller KL, Liang LC, Sakimura J, May D, van Belle C, Breen C, Driggin E, Tepper BJ, Lanzano PC, Deng L, Chung WK. Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African Americans. Obesity. 2012;20:1066–73.PubMedPubMedCentralCrossRef
46.
Mattes RD. Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans. Am J Physiol Gastrointest Liver Physiol. 2009;296:G365–71.PubMedCrossRef
47.
Martin C, Passilly-Degrace P, Gaillard D, Merlin JF, Chevrot M, Besnard P. The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference. PLoS One. 2011;6:e24014.PubMedPubMedCentralCrossRef
48.
Rolls BJ, Rowe EA, Rolls ET, Kingston B, Megson A, Gunary R. Variety in a meal enhances food intake in man. Physiol Behav. 1981;26:215–21.PubMedCrossRef
49.
Cai H, Cong WN, Daimon CM, Wang R, Tschop MH, Sevigny J, Martin B, Maudsley S. Altered lipid and salt taste responsivity in ghrelin and GOAT null mice. PLoS One. 2013;8:e76553.PubMedPubMedCentralCrossRef
50.
DiPatrizio NV, Joslin A, Jung KM, Piomelli D. Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. FASEB J. 2013;27:2513–20.PubMedPubMedCentralCrossRef
51.
Shin AC, Townsend RL, Patterson LM, Berthoud HR. “liking” and “wanting” of sweet and oily food stimuli as affected by high-fat diet-induced obesity, weight loss, leptin, and genetic predisposition. Am J Phys Regul Integr Comp Phys. 2011;301:R1267–80.
52.
Running CA, Craig BA, Mattes RD. Oleogustus: the unique taste of fat. Chem Senses. 2015;40:507–16.PubMedCrossRef
53.
Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol. 2008;117:924–35.PubMedPubMedCentralCrossRef
54.
Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr. 1998;68:1157–73.PubMed
55.
Chevrot M, Bernard A, Ancel D, Buttet M, Martin C, Abdoul-Azize S, Merlin JF, Poirier H, Niot I, Khan NA, Passilly-Degrace P, Besnard P. Obesity alters the gustatory perception of lipids in the mouse: plausible involvement of lingual CD36. J Lipid Res. 2013;54:2485–94.PubMedPubMedCentralCrossRef
56.
Stewart JE, Feinle-Bisset C, Golding M, Delahunty C, Clifton PM, Keast RS. Oral sensitivity to fatty acids, food consumption and BMI in human subjects. Brit J Nutr. 2010;104:145–52.PubMedCrossRef
57.
Stewart JE, Feinle-Bisset C, Keast RS. Fatty acid detection during food consumption and digestion: associations with ingestive behavior and obesity. Prog Lipid Res. 2011;50:225–33.PubMedCrossRef
58.
Stewart JE, Seimon RV, Otto B, Keast RS, Clifton PM, Feinle-Bisset C. Marked differences in gustatory and gastrointestinal sensitivity to oleic acid between lean and obese men. Am J Clin Nutr. 2011;93:703–11.PubMedCrossRef
59.
Stewart JE, Keast RS. Recent fat intake modulates fat taste sensitivity in lean and overweight subjects. Int J Obes. 2012;36:834–42.CrossRef
60.
61.
Tucker RM, Nuessle TM, Garneau NL, Smutzer G, Mattes RD. No difference in perceived intensity of linoleic acid in the oral cavity between obese and Nonobese individuals. Chem Senses. 2015;40:557–63.PubMedPubMedCentralCrossRef
62.
Tucker RM, Mattes RD. Influences of repeated testing on nonesterified fatty acid taste. Chem Senses. 2013;38:325–32.PubMedCrossRef
63.
Mattes RD. Oral fat exposure alters postprandial lipid metabolism in humans. Am J Clin Nutr. 1996;63:911–7.PubMed
64.
Chavez-Jauregui RN, Mattes RD, Parks EJ. Dynamics of fat absorption and effect of sham feeding on postprandial lipema. Gastroenterology. 2010;139:1538–48.PubMedCrossRef
65.
Cansell C, Castel J, Denis RG, Rouch C, Delbes AS, Martinez S, Mestivier D, Finan B, Maldonado-Aviles JG, Rijnsburger M, Tschop MH, DiLeone RJ, Eckel RH, la Fleur SE, Magnan C, Hnasko TS, Luquet S. Dietary triglycerides act on mesolimbic structures to regulate the rewarding and motivational aspects of feeding. Mol Psychiatry. 2014;19:1095–105.PubMedPubMedCentralCrossRef
66.
Duffy VB. Variation in oral sensation: implications for diet and health. Curr Opin Gastroenterol. 2007;23:171–7.PubMedCrossRef
67.
Proserpio C, Laureati M, Bertoli S, Battezzati A, Pagliarini E. Determinants of obesity in Italian adults: the role of taste sensitivity, food liking, and food Neophobia. Chem Senses. 2016;41:169–76.PubMed
68.
Miller Jr IJ, Reedy Jr FE. Variations in human taste bud density and taste intensity perception. Physiol Behav. 1990;47:1213–121.PubMedCrossRef
69.
Garneau NL, Nuessle TM, Sloan MM, Santorico SA, Coughlin BC, Hayes JE. Crowdsourcing taste research: genetic and phenotypic predictors of bitter taste perception as a model. Front Integr Neurosci. 2014;8:33.PubMedPubMedCentralCrossRef
70.
Vors C, Drai J, Gabert L, Pineau G, Laville M, Vidal H, Guichard E, Michalski MC, Feron G. Salivary composition in obese vs normal-weight subjects: towards a role in postprandial lipid metabolism? Int J Obes. 2015;39:1425–8.CrossRef
71.
Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J, DeFronzo RA, Fox PT, Gao JH. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes. 1999;48:1801–6.PubMedCrossRef
72.
Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, Ravussin E, Reiman EM, Tataranni PA. Differential brain responses to satiation in obese and lean men. Diabetes. 2000;49:838–46.PubMedCrossRef
73.
Stoeckel LE, Weller RE, Cook 3rd EW, Twieg DB, Knowlton RC, Cox JE. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. NeuroImage. 2008;41:636–47.PubMedCrossRef
74.
DelParigi A, Chen K, Salbe AD, Reiman EM, Tataranni PA. Sensory experience of food and obesity: a positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast. NeuroImage. 2005;24:436–43.PubMedCrossRef
75.
Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA. Brain abnormalities in human obesity: a voxel-based morphometric study. NeuroImage. 2006;31:1419–25.PubMedCrossRef
76.
Velloso LA, Schwartz MW. Altered hypothalamic function in diet-induced obesity. Int J Obes. 2011;35:1455–65.CrossRef
77.
Berthoud HR, Zheng H, Shin AC. Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery. Ann N Y Acad Sci. 2012;1264:36–48.PubMedPubMedCentralCrossRef
78.
Valdivia S, Patrone A, Reynaldo M, Perello M. Acute high fat diet consumption activates the mesolimbic circuit and requires orexin signaling in a mouse model. PLoS One. 2014;9:e87478.PubMedPubMedCentralCrossRef
79.
Liang NC, Hajnal A, Norgren R. Sham feeding corn oil increases accumbens dopamine in the rat. Am J Phys Regul Integr Comp Phys. 2006;291:R1236–9.
80.
81.
Vucetic Z, Kimmel J, Reyes TM. Chronic high-fat diet drives postnatal epigenetic regulation of mu-opioid receptor in the brain. Neuropsychopharmacol. 2011;36:1199–206.CrossRef
82.
Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci. 2004;27:107–44.PubMedCrossRef
83.
Volkow ND, Wang GJ, Tomasi D, Baler RD. Obesity and addiction: neurobiological overlaps. Obes Rev. 2013;14:2–18.PubMedCrossRef
84.
de Weijer BA, van de Giessen E, van Amelsvoort TA, Boot E, Braak B, Janssen IM, van de Laar A, Fliers E, Serlie MJ, Booij J. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res. 2011;1:37.PubMedPubMedCentralCrossRef
85.
Haltia LT, Rinne JO, Merisaari H, Maguire RP, Savontaus E, Helin S, Nagren K, Kaasinen V. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse. 2007;61:748–56.PubMedCrossRef
86.
Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS. Brain dopamine and obesity. Lancet. 2001;357:354–7.PubMedCrossRef
87.
Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA, Arbelaez AM, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol. Synapse. 2013;67:748–56.PubMedPubMedCentralCrossRef
88.
Kessler RM, Zald DH, Ansari MS, Li R, Cowan RL. Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity. Synapse. 2014;68:317–20.PubMed
89.
Dunn JP, Kessler RM, Feurer ID, Volkow ND, Patterson BW, Ansari MS, Li R, Marks-Shulman P, Abumrad NN. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care. 2012;35:1105–11.PubMedPubMedCentralCrossRef
90.
Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD. Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry. 2014;19:1078–84.PubMedPubMedCentralCrossRef
91.
Carnell S, Gibson C, Benson L, Ochner CN, Geliebter A. Neuroimaging and obesity: current knowledge and future directions. Obes Rev. 2012;13:43–56.PubMedCrossRef
92.
Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG. The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 2010;1350:43–64.PubMedPubMedCentralCrossRef
93.
Berthoud HR, Lenard NR, Shin AC. Food reward, hyperphagia, and obesity. Am J Phys Regul Integr Comp Phys. 2011;300:R1266–77.
94.
le Roux CW, Bueter M, Theis N, Werling M, Ashrafian H, Lowenstein C, Athanasiou T, Bloom SR, Spector AC, Olbers T, Lutz TA. Gastric bypass reduces fat intake and preference. Am J Phys Regul Integr Comp Phys. 2011;301:R1057–66.
95.
Zheng H, Shin AC, Lenard NR, Townsend RL, Patterson LM, Sigalet DL, Berthoud HR. Meal patterns, satiety, and food choice in a rat model of roux-en-Y gastric bypass surgery. Am J Phys Regul Integr Comp Phys. 2009;297:R1273–82.
96.
Mathes CM, Spector AC. Food selection and taste changes in humans after roux-en-Y gastric bypass surgery: a direct-measures approach. Physiol Behav. 2012;107:476–83.PubMedCrossRef
97.
Lutz TA, Bueter M. The physiology underlying roux-en-Y gastric bypass: a status report. Am J Phys Regul Integr Comp Phys. 2014;307:R1275–91.
98.
Miras AD, le Roux CW. Bariatric surgery and taste: novel mechanisms of weight loss. Curr Opin Gastroenterol. 2010;26:140–5.PubMedCrossRef
99.
Behary P, Miras AD. Food preferences and underlying mechanisms after bariatric surgery. Proc Nutr Soc. 2015;74:419–25.PubMedCrossRef
100.
Ochner CN, Kwok Y, Conceicao E, Pantazatos SP, Puma LM, Carnell S, Teixeira J, Hirsch J, Geliebter A. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg. 2011;253:502–7.PubMedPubMedCentralCrossRef
101.
Scholtz S, Miras AD, Chhina N, Prechtl CG, Sleeth ML, Daud NM, Ismail NA, Durighel G, Ahmed AR, Olbers T, Vincent RP, Alaghband-Zadeh J, Ghatei MA, Waldman AD, Frost GS, Bell JD, le Roux CW, Goldstone AP. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut. 2014;63:891–902.PubMedCrossRef
102.
Zolotukhin S. Metabolic hormones in saliva: origins and functions. Oral Dis. 2013;19:219–29.PubMed
103.
Shin YK, Martin B, Golden E, Dotson CD, Maudsley S, Kim W, Jang HJ, Mattson MP, Drucker DJ, Egan JM, Munger SD. Modulation of taste sensitivity by GLP-1 signaling. J Neurochem. 2008;106:455–63.PubMedPubMedCentralCrossRef
104.
Kawai K, Sugimoto K, Nakashima K, Miura H, Ninomiya Y. Leptin as a modulator of sweet taste sensitivities in mice. Proc Natl Acad Sci U S A. 2000;97:11044–9.PubMedPubMedCentralCrossRef
105.
Nakamura Y, Sanematsu K, Ohta R, Shirosaki S, Koyano K, Nonaka K, Shigemura N, Ninomiya Y. Diurnal variation of human sweet taste recognition thresholds is correlated with plasma leptin levels. Diabetes. 2008;57:2661–5.PubMedPubMedCentralCrossRef
106.
Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety–effect of obesity and weight reduction. Int J Obes Relat Metab Disord. 2001;25:1206–14.PubMedCrossRef
107.
Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12:962–71.PubMedCrossRef
108.
Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518–25.PubMedCrossRef
109.
110.
Wang XF, Liu JJ, Xia J, Liu J, Mirabella V, Pang ZP. Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons. Cell Rep. 2015;12:726–33.PubMedPubMedCentralCrossRef
111.
van Bloemendaal L, IJ RG, JS TK, Barkhof F, RJ K, ML D, DJ V, Diamant M. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes. 2014;63:4186–96.PubMedCrossRef
112.
Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–800.PubMedCrossRef
113.
Ha CW, Lam YY, Holmes AJ. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol. 2014;20:16498–517.PubMedPubMedCentralCrossRef
114.
Teng KT, Chang CY, Chang LF, Nesaretnam K. Modulation of obesity-induced inflammation by dietary fats: mechanisms and clinical evidence. Nutr J. 2014;13:12.PubMedPubMedCentralCrossRef
115.
Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio MC. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res. 2012;32:637–47.PubMedCrossRef
116.
117.
Cohn ZJ, Kim A, Huang L, Brand J, Wang H. Lipopolysaccharide-induced inflammation attenuates taste progenitor cell proliferation and shortens the life span of taste bud cells. BMC Neurosci. 2010;11:72.PubMedPubMedCentralCrossRef
118.
119.
Cazettes F, Cohen JI, Yau PL, Talbot H, Convit A. Obesity-mediated inflammation may damage the brain circuit that regulates food intake. Brain Res. 2011;1373:101–9.PubMedCrossRef
120.
Lee S, Eguchi A, Tsuzuki S, Matsumura S, Inoue K, Iwanaga T, Masuda D, Yamashita S, Fushiki T. Expression of CD36 by olfactory receptor cells and its abundance on the epithelial surface in mice. PLoS One. 2015;10:e0133412.PubMedPubMedCentralCrossRef
121.
Oberland S, Ackels T, Gaab S, Pelz T, Spehr J, Spehr M, Neuhaus EM. CD36 is involved in oleic acid detection by the murine olfactory system. Front Cell Neurosci. 2015;9:366.PubMedPubMedCentralCrossRef
122.
Lacroix MC, Caillol M, Durieux D, Monnerie R, Grebert D, Pellerin L, Repond C, Tolle V, Zizzari P, Baly C. Long-lasting metabolic imbalance related to obesity alters olfactory tissue homeostasis and impairs olfactory-driven behaviors. Chem Senses. 2015;40:537–56.PubMedCrossRef
Metadata
Title
Lipids and obesity: Also a matter of taste?
Author
Philippe Besnard
Publication date
01-06-2016
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2016
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9355-2

Other articles of this Issue 2/2016

Reviews in Endocrine and Metabolic Disorders 2/2016 Go to the issue

ReviewPaper

Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future research

EditorialNotes

Introduction to the sense of taste in endocrinology

ReviewPaper

Artificial sweeteners and metabolic dysregulation: Lessons learned from agriculture and the laboratory

ReviewPaper

Recent advances in the modification of taste and food preferences following bariatric surgery

ReviewPaper

The development of sweet taste: From biology to hedonics

ReviewPaper

A Genome-Wide Association Study in isolated populations reveals new genes associated to common food likings
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits